{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:00:33Z","timestamp":1791349233587,"version":"4.3.1"},"reference-count":150,"publisher":"Bentham Science Publishers Ltd.","issue":"21","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Statins are HMG-CoA reductase inhibitors and decrease plasma low-density\nlipoprotein cholesterol (LDL-C) levels. They are well tolerated, and because of their\nLDL-C-lowering effect, they are utilized to decrease the risk of atherosclerosis and cardiovascular\ndisease. However, statins have pleiotropic effects, including immunomodulatory,\nanti-inflammatory, antioxidant, and anticancer. Currently, oral administration is the\nonly Food and Drug Administration (FDA)-approved route of administration for statins.\nHowever, other administration routes have demonstrated promising results in different\npre-clinical and clinical studies. For instance, statins also seem beneficial in dermatitis,\npsoriasis, vitiligo, hirsutism, uremic pruritus, and graft-versus-host disease. Topically applied\nstatins have been studied to treat seborrhea, acne, rhinophyma, and rosacea. They also\nhave beneficial effects in contact dermatitis and wound healing in animal studies,\n(HIV) infection, osseointegration, porokeratosis, and some ophthalmologic diseases. Topical\nand transdermal application of statins is a non-invasive drug administration method\nthat has shown significant results in bypassing the first-pass metabolism in the liver,\nthereby reducing possible adverse effects. This study reviews the multifaceted molecular\nand cellular impacts of statins, their topical and transdermal application, novel delivery\nsystems, such as nanosystems for topical and transdermal administration and the challenges\nconcerning this approach.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867330666230508141434","type":"journal-article","created":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T05:10:32Z","timestamp":1683609032000},"page":"3149-3166","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Therapeutic Effects of Statins: Promising Drug for Topical and\nTransdermal Administration"],"prefix":"10.2174","volume":"31","author":[{"given":"Fatemeh","family":"Zahedipour","sequence":"first","affiliation":[{"name":"Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran"},{"name":"Department of Medical Biotechnology and Nanotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyede Atefe","family":"Hosseini","sequence":"additional","affiliation":[{"name":"Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran"},{"name":"Department of Medical Biotechnology and Nanotechnology, Faculty of Medicine, Mashhad University\nof Medical Sciences, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u017deljko","family":"Reiner","sequence":"additional","affiliation":[{"name":"University Hospital Center Zagreb, Department of Internal Medicine, Zagreb, Croatia"},{"name":"Polish Mother's Memorial Hospital Research Institute, Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Tedeschi-Reiner","sequence":"additional","affiliation":[{"name":"University Hospital Sestre Milosrdnice, Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tannaz","family":"Jamialahmadi","sequence":"additional","affiliation":[{"name":"Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[{"name":"Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran"},{"name":"Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s00210-016-1252-4","volume":"389","author":"Bedi O.","year":"2016","unstructured":"Bedi O.; Dhawan V.; Sharma P.L.; Kumar P.; Pleiotropic effects of statins: new therapeutic targets in drug design. Naunyn Schmiedebergs Arch Pharmacol  2016,389(7),695-712","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"101024","DOI":"10.1016\/j.arr.2020.101024","volume":"58","author":"Bahrami A.","year":"2020","unstructured":"Bahrami A.; Bo S.; Jamialahmadi T.; Sahebkar A.; Effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on ageing: Molecular mechanisms. Ageing Res Rev  2020,58,101024","journal-title":"Ageing Res Rev"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"105986","DOI":"10.1016\/j.phrs.2021.105986","volume":"175","author":"Bland A.R.","year":"2022","unstructured":"Bland A.R.; Payne F.M.; Ashton J.C.; Jamialahmadi T.; Sahebkar A.; The cardioprotective actions of statins in targeting mitochondrial dysfunction associated with myocardial ischaemia-reperfusion injury. Pharmacol Res  2022,175,105986","journal-title":"Pharmacol Res"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.plipres.2015.08.003","volume":"60","author":"Ferretti G.","year":"2015","unstructured":"Ferretti G.; Bacchetti T.; Sahebkar A.; Effect of statin therapy on paraoxonase-1 status: A systematic review and meta-analysis of 25 clinical trials. Prog Lipid Res  2015,60,50-73","journal-title":"Prog Lipid Res"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s11745-010-3517-x","volume":"46","author":"Parizadeh S.M.R.","year":"2011","unstructured":"Parizadeh S.M.R.; Azarpazhooh M.R.; Moohebati M.; Nematy M.; Ghayour-Mobarhan M.; Tavallaie S.; Rahsepar A.A.; Amini M.; Sahebkar A.; Mohammadi M.; Ferns G.A.A.; Simvastatin therapy reduces prooxidant-antioxidant balance: results of a placebo-controlled cross-over trial. Lipids  2011,46(4),333-340","journal-title":"Lipids"},{"key":"ref=6","doi-asserted-by":"publisher","unstructured":"Sahebkar, A.; Chew, G.T.; Watts, G.F. Recent advances in\npharmacotherapy for hypertriglyceridemia. Prog. Lipid Res. ,  2014,  56(1), 47-66.","DOI":"10.1016\/j.plipres.2014.07.002"},{"key":"ref=7","doi-asserted-by":"publisher","unstructured":"Koushki, K., Shahbaz, S. K., Mashayekhi, K., Sadeghi, M., Zayeri, Z. D., Taba, M. Y., Banach, M., Al-Rasadi, K., Johnston, T. P., and Sahebkar, A. Anti-inflammatory action of statins in cardiovascular disease: The role of inflammasome and toll-Like receptor pathways. Clinical reviews in allergy and immunology,, 2021, 60(2), 175\u2013199.","DOI":"10.1007\/s12016-020-08791-9"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1160\/TH14-11-0937","volume":"114","author":"Sahebkar A.","year":"2015","unstructured":"Sahebkar A.; Serban C.; Mikhailidis D.P.; Undas A.; Lip G.Y.H.; Muntner P.; Bittner V.; Ray K.K.; Watts G.F.; Hovingh G.K.; Rysz J.; Kastelein J.J.; Banach M.; Association between statin use and plasma D-dimer levels. A systematic review and meta-analysis of randomised controlled trials. Thromb Haemost  2015,114(3),546-557","journal-title":"Thromb Haemost"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.5114\/aoms.2019.89330","volume":"17","author":"Sohrevardi S.","year":"2019","unstructured":"Sohrevardi S.; Nasab F.; Mirjalili M.; Bagherniya M.; Tafti A.; Jarrahzadeh M.; Azarpazhooh M.; Saeidmanesh M.; Banach M.; Jamialahmadi T.; Sahebkar A.; Effect of atorvastatin on delirium status of patients in the intensive care unit: A randomized controlled trial. Arch Med Sci  2019,17(5),1423-1428","journal-title":"Arch Med Sci"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nri1839","volume":"6","author":"Greenwood J.","year":"2006","unstructured":"Greenwood J.; Steinman L.; Zamvil S.S.; Statin therapy and autoimmune disease: From protein prenylation to immunomodulation. Nat Rev Immunol  2006,6(5),358-370","journal-title":"Nat Rev Immunol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/j.1365-2125.2011.04139.x","volume":"73","author":"Davignon J.","year":"2012","unstructured":"Davignon J.; Pleiotropic effects of pitavastatin. Br J Clin Pharmacol  2012,73(4),518-535","journal-title":"Br J Clin Pharmacol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s00204-011-0772-4","volume":"86","author":"Viola G.","year":"2012","unstructured":"Viola G.; Grobelny P.; Linardi M.A.; Salvador A.; Dall\u2019Acqua S.; Sobotta \u0141.; Mielcarek J.; Dall\u2019Acqua F.; Vedaldi D.; Basso G.; Pitavastatin, a new HMG-CoA reductase inhibitor, induces phototoxicity in human keratinocytes NCTC-2544 through the formation of benzophenanthridine-like photoproducts. Arch Toxicol  2012,86(3),483-496","journal-title":"Arch Toxicol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1124\/dmd.112.045666","volume":"40","author":"Li J.","year":"2012","unstructured":"Li J.; Wang Y.; Zhang W.; Huang Y.; Hein K.; Hidalgo I.J.; The role of a basolateral transporter in rosuvastatin transport and its interplay with apical breast cancer resistance protein in polarized cell monolayer systems. Drug Metab Dispos  2012,40(11),2102-2108","journal-title":"Drug Metab Dispos"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1093\/eurheartj\/ehac015","volume":"43","author":"Byty\u00e7i I.","year":"2022","unstructured":"Byty\u00e7i I.; Penson P.E.; Mikhailidis D.P.; Wong N.D.; Hernandez A.V.; Sahebkar A.; Thompson P.D.; Mazidi M.; Rysz J.; Pella D.; Reiner \u017d.; Toth P.P.; Banach M.; Prevalence of statin intolerance: A meta-analysis. Eur Heart J  2022,43(34),3213-3223","journal-title":"Eur Heart J"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1161\/CIRCRESAHA.118.312782","volume":"124","author":"Ward N.C.","year":"2019","unstructured":"Ward N.C.; Watts G.F.; Eckel R.H.; Statin toxicity. Circ Res  2019,124(2),328-350","journal-title":"Circ Res"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.phrs.2015.07.008","volume":"99","author":"Banach M.","year":"2015","unstructured":"Banach M.; Serban C.; Ursoniu S.; Rysz J.; Muntner P.; Toth P.P.; Jones S.R.; Rizzo M.; Glasser S.P.; Watts G.F.; Blumenthal R.S.; Lip G.Y.H.; Mikhailidis D.P.; Sahebkar A.; Statin therapy and plasma coenzyme Q10 concentrations\u2014A systematic review and meta-analysis of placebo-controlled trials. Pharmacol Res  2015,99,329-336","journal-title":"Pharmacol Res"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nrd1112","volume":"2","author":"Tobert J.A.","year":"2003","unstructured":"Tobert J.A.; Lovastatin and beyond: The history of the HMG-CoA reductase inhibitors. Nat Rev Drug Discov  2003,2(7),517-526","journal-title":"Nat Rev Drug Discov"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrcardio.2013.80","volume":"10","author":"Reiner \u017d.","year":"2013","unstructured":"Reiner \u017d.; Statins in the primary prevention of cardiovascular disease. Nat Rev Cardiol  2013,10(8),453-464","journal-title":"Nat Rev Cardiol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.neuroscience.2016.04.053","volume":"329","author":"Ostrowski S.M.","year":"2016","unstructured":"Ostrowski S.M.; Johnson K.; Siefert M.; Shank S.; Sironi L.; Wolozin B.; Landreth G.E.; Ziady A.G.; Simvastatin inhibits protein isoprenylation in the brain. Neuroscience  2016,329,264-274","journal-title":"Neuroscience"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/ana.21731","volume":"66","author":"Abrahamson E.E.","year":"2009","unstructured":"Abrahamson E.E.; Ikonomovic M.D.; Dixon C.E.; DeKosky S.T.; Simvastatin therapy prevents brain trauma-induced increases in \u03b2-amyloid peptide levels. Ann Neurol  2009,66(3),407-414","journal-title":"Ann Neurol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"725","DOI":"10.4103\/0973-1482.146127","volume":"12","author":"Ostad S.N.","year":"2016","unstructured":"Ostad S.N.; Afzali M.; Vatankhah M.; Investigation of simvastatin-induced apoptosis and cell cycle arrest in cancer stem cells of MCF-7. J Cancer Res Ther  2016,12(2),725-730","journal-title":"J Cancer Res Ther"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.4143\/crt.2018.379","volume":"51","author":"Kim Y.","year":"2019","unstructured":"Kim Y.; Kim T.W.; Han S.W.; Ahn J.B.; Kim S.T.; Lee J.; Park J.O.; Park Y.S.; Lim H.Y.; Kang W.K.; A single arm, phase II study of simvastatin plus XELOX and bevacizumab as first-line chemotherapy in metastatic colorectal cancer patients. Cancer Res Treat  2019,51(3),1128-1134","journal-title":"Cancer Res Treat"},{"key":"ref=23","first-page":"1255","volume":"11","author":"Li N.","year":"2019","unstructured":"Li N.; Xie X.; Hu Y.; He H.; Fu X.; Fang T.; Li C.; Herceptin-conjugated liposomes co-loaded with doxorubicin and simvastatin in targeted prostate cancer therapy. Am J Transl Res  2019,11(3),1255-1269","journal-title":"Am J Transl Res"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1111\/cas.14312","volume":"111","author":"Luput L.","year":"2020","unstructured":"Luput L.; Sesarman A.; Porfire A.; Achim M.; Muntean D.; Casian T.; Patras L.; Rauca V.F.; Drotar D.M.; Stejerean I.; Tomuta I.; Vlase L.; Dragos N.; Toma V.A.; Licarete E.; Banciu M.; Liposomal simvastatin sensitizes C26 murine colon carcinoma to the antitumor effects of liposomal 5-fluorouracil in vivo. Cancer Sci  2020,111(4),1344-1356","journal-title":"Cancer Sci"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"e0196713","DOI":"10.1371\/journal.pone.0196713","volume":"13","author":"Lin T-K","year":"2018","unstructured":"Lin T-K; Chou P; Lin C-H; Hung Y-J; Jong G-P; Long-term effect of statins on the risk of new-onset osteoporosis: A nationwide population-based cohort study. PLoS One  2018,13(5),e0196713","journal-title":"PLoS One"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1136\/annrheumdis-2019-215714","volume":"78","author":"Leutner M.","year":"2019","unstructured":"Leutner M.; Matzhold C.; Bellach L.; Deischinger C.; Harreiter J.; Thurner S.; Klimek P.; Kautzky-Willer A.; Diagnosis of osteoporosis in statin-treated patients is dose-dependent. Ann Rheum Dis  2019,78(12),1706-1711","journal-title":"Ann Rheum Dis"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/hiv.12794","volume":"21","author":"Blackman A.L.","year":"2020","unstructured":"Blackman A.L.; Pandit N.S.; Pincus K.J.; Comparing rates of statin therapy in eligible patients living with HIV versus uninfected patients. HIV Med  2020,21(3),135-141","journal-title":"HIV Med"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1111\/j.1365-4632.2010.04579.x","volume":"49","author":"Jowkar F.","year":"2010","unstructured":"Jowkar F.; Namazi M.R.; Statins in dermatology. Int J Dermatol  2010,49(11),1235-1243","journal-title":"Int J Dermatol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"497","DOI":"10.11607\/jomi.4955","volume":"32","author":"Kellesarian S.","year":"2017","unstructured":"Kellesarian S.; Al Amri M.; Al-Kheraif A.; Ghanem A.; Malmstrom H.; Javed F.; Efficacy of local and systemic statin delivery on the osseointegration of implants: A systematic Review. Int J Oral Maxillofac Implants  2017,32(3),497-506","journal-title":"Int J Oral Maxillofac Implants"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jobcr.2020.04.004","volume":"10","author":"Dundar S.","year":"2020","unstructured":"Dundar S.; Bozoglan A.; Evaluation of the effects of topically applied simvastatin on titanium implant osseointegration. J Oral Biol Craniofac Res  2020,10(2),149-152","journal-title":"J Oral Biol Craniofac Res"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jaad.2019.08.043","volume":"82","author":"Atzmony L.","year":"2020","unstructured":"Atzmony L.; Lim Y.H.; Hamilton C.; Leventhal J.S.; Wagner A.; Paller A.S.; Choate K.A.; Topical cholesterol\/lovastatin for the treatment of porokeratosis: A pathogenesis-directed therapy. J Am Acad Dermatol  2020,82(1),123-131","journal-title":"J Am Acad Dermatol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1159\/000178868","volume":"22","author":"Auger F.A.","year":"2009","unstructured":"Auger F.A.; Lacroix D.; Germain L.; Skin substitutes and wound healing. Skin Pharmacol Physiol  2009,22(2),94-102","journal-title":"Skin Pharmacol Physiol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3109\/07853890008998823","volume":"32","author":"Bellosta S.","year":"2000","unstructured":"Bellosta S.; Fed N.; Bernini F.; Paoletti R.; Corsini A.; Non-lipid-related effects of statins. Ann Med  2000,32(3),164-176","journal-title":"Ann Med"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"343","DOI":"10.2165\/00003088-200241050-00003","volume":"41","author":"Williams D.","year":"2002","unstructured":"Williams D.; Feely J.; Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors. Clin Pharmacokinet  2002,41(5),343-370","journal-title":"Clin Pharmacokinet"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.2174\/1381612820666141013134447","volume":"21","author":"\u0160imi\u0107 I.","year":"2015","unstructured":"\u0160imi\u0107 I.; Reiner Z.; Adverse effects of statins - myths and reality. Curr Pharm Des  2015,21(9),1220-1226","journal-title":"Curr Pharm Des"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.numecd.2014.05.009","volume":"24","author":"Reiner \u017d.","year":"2014","unstructured":"Reiner \u017d.; Resistance and intolerance to statins. Nutr Metab Cardiovasc Dis  2014,24(10),1057-1066","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"104956","DOI":"10.1016\/j.ejps.2019.104956","volume":"136","author":"Kaur R.","year":"2019","unstructured":"Kaur R.; Ajitha M.; Transdermal delivery of fluvastatin loaded nanoemulsion gel: Preparation, characterization and in vivo anti-osteoporosis activity. Eur J Pharm Sci  2019,136,104956","journal-title":"Eur J Pharm Sci"},{"key":"ref=38","first-page":"1191","volume":"25","author":"Prueksaritanont T.","year":"1997","unstructured":"Prueksaritanont T.; Gorham L.M.; Ma B.; Liu L.; Yu X.; Zhao J.J.; Slaughter D.E.; Arison B.H.; Vyas K.P.; In vitro metabolism of simvastatin in humans [SBT]identification of metabolizing enzymes and effect of the drug on hepatic P450s. Drug Metab Dispos  1997,25(10),1191-1199","journal-title":"Drug Metab Dispos"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1046\/j.1365-2125.2003.01833.x","volume":"56","author":"Prueksaritanont T.","year":"2003","unstructured":"Prueksaritanont T.; Ma B.; Yu N.; The human hepatic metabolism of simvastatin hydroxy acid is mediated primarily by CYP3A, and not CYP2D6. Br J Clin Pharmacol  2003,56(1),120-124","journal-title":"Br J Clin Pharmacol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1124\/pr.115.011411","volume":"68","author":"Backman J.T.","year":"2016","unstructured":"Backman J.T.; Filppula A.M.; Niemi M.; Neuvonen P.J.; Role of cytochrome P450 2C8 in drug metabolism and interactions. Pharmacol Rev  2016,68(1),168-241","journal-title":"Pharmacol Rev"},{"key":"ref=41","first-page":"580","volume":"58","author":"Liu Y.","year":"2008","unstructured":"Liu Y.; Zeng B.H.; Shang H.T.; Cen Y.Y.; Wei H.; Bama miniature pigs (Sus scrofa domestica) as a model for drug evaluation for humans: Comparison of in vitro metabolism and in vivo pharmacokinetics of lovastatin. Comp Med  2008,58(6),580-587","journal-title":"Comp Med"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1007\/s00216-007-1169-3","volume":"387","author":"Li M.","year":"2007","unstructured":"Li M.; Fan L.Y.; Zhang W.; Cao C.X.; Stacking and quantitative analysis of lovastatin in urine samples by the transient moving chemical reaction boundary method in capillary electrophoresis. Anal Bioanal Chem  2007,387(8),2719-2725","journal-title":"Anal Bioanal Chem"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.pharmthera.2018.10.004","volume":"195","author":"Liu A.","year":"2019","unstructured":"Liu A.; Wu Q.; Guo J.; Ares I.; Rodr\u00edguez J.L.; Mart\u00ednez-Larra\u00f1aga M.R.; Yuan Z.; Anad\u00f3n A.; Wang X.; Mart\u00ednez M.A.; Statins: Adverse reactions, oxidative stress and metabolic interactions. Pharmacol Ther  2019,195,54-84","journal-title":"Pharmacol Ther"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0021-9150(03)00290-9","volume":"171","author":"Sprecher D.L.","year":"2003","unstructured":"Sprecher D.L.; Goodman S.G.; Kannampuzha P.; Pearce G.L.; Langer A.; Skin tissue cholesterol (SkinTc) is related to angiographically-defined cardiovascular disease. Atherosclerosis  2003,171(2),255-258","journal-title":"Atherosclerosis"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2174\/1567201043334579","volume":"1","author":"Babita K.","year":"2004","unstructured":"Babita K.; Tiwary A.; Skin lipid synthesis inhibition: A possible means for enhancing percutaneous delivery of levodopa. Curr Drug Deliv  2004,1(4),397-403","journal-title":"Curr Drug Deliv"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1159\/000246368","volume":"192","author":"Brazzell V.","year":"1996","unstructured":"Brazzell V.; Distante F.; Perani G.; Berardesca E.; Effects of systemic treatment with statins on skin barrier function and stratum corneum water-holding capacity. Dermatology  1996,192(3),214-216","journal-title":"Dermatology"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/0026-0495(91)90235-O","volume":"40","author":"Dobs A.S.","year":"1991","unstructured":"Dobs A.S.; Levine M.A.; Margolis S.; Effects of pravastatin, a new HMG-CoA reductase inhibitor, on vitamin D synthesis in man. Metabolism  1991,40(5),524-528","journal-title":"Metabolism"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1001\/jama.286.1.64","volume":"286","author":"Albert M.A.","year":"2001","unstructured":"Albert M.A.; Danielson E.; Rifai N.; Ridker P.M.; Effect of statin therapy on C-reactive protein levels: The pravastatin inflammation\/CRP evaluation (PRINCE): A randomized trial and cohort study. JAMA  2001,286(1),64-70","journal-title":"JAMA"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0167-5273(00)00439-3","volume":"77","author":"Musial J.","year":"2001","unstructured":"Musial J.; Undas A.; Gajewski P.; Jankowski M.; Sydor W.; Szczeklik A.; Anti-inflammatory effects of simvastatin in subjects with hypercholesterolemia. Int J Cardiol  2001,77(2-3),247-253","journal-title":"Int J Cardiol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1161\/01.CIR.0000080289.72166.CF","volume":"108","author":"Albert M.A.","year":"2003","unstructured":"Albert M.A.; Glynn R.J.; Ridker P.M.; Plasma concentration of C-reactive protein and the calculated framingham coronary heart disease risk score. Circulation  2003,108(2),161-165","journal-title":"Circulation"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"OC32","DOI":"10.7860\/JCDR\/2016\/16538.7814","volume":"10","author":"Mowla K.","year":"2016","unstructured":"Mowla K.; Rajai E.; Ghorbani A.; Dargahi-Malamir M.; Bahadoram M.; Mohammadi S.; Effect of atorvastatin on the disease activity and severity of rheumatoid arthritis: Double-blind randomized controlled trial. J Clin Diagn Res  2016,10(5),OC32-OC36","journal-title":"J Clin Diagn Res"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/art.21564","volume":"54","author":"Nagashima T.","year":"2006","unstructured":"Nagashima T.; Okazaki H.; Yudoh K.; Matsuno H.; Minota S.; Apoptosis of rheumatoid synovial cells by statins through the blocking of protein geranylgeranylation: A potential therapeutic approach to rheumatoid arthritis. Arthritis Rheum  2006,54(2),579-586","journal-title":"Arthritis Rheum"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1097\/01.ASN.0000018400.39687.8C","volume":"13","author":"Palinski W.","year":"2002","unstructured":"Palinski W.; Tsimikas S.; Immunomodulatory effects of statins: mechanisms and potential impact on arteriosclerosis. J Am Soc Nephrol  2002,13(6),1673-1681","journal-title":"J Am Soc Nephrol"},{"key":"ref=54","first-page":"135","author":"Kittleson M.M.","year":"2013","unstructured":"Kittleson M.M.; Kobashigawa J.A.; Statins in heart transplantation. Clin Transpl  2013,135-143","journal-title":"Clin Transpl"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1016\/S0140-6736(13)62242-4","volume":"383","author":"Chataway J.","year":"2014","unstructured":"Chataway J.; Schuerer N.; Alsanousi A.; Chan D.; Mac-Manus D.; Hunter K.; Anderson V.; Bangham C.R.M.; Clegg S.; Nielsen C.; Fox N.C.; Wilkie D.; Nicholas J.M.; Calder V.L.; Greenwood J.; Frost C.; Nicholas R.; Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): A randomised, placebo-controlled, phase 2 trial. Lancet  2014,383(9936),2213-2221","journal-title":"Lancet"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1007\/s00415-012-6513-7","volume":"259","author":"Kamm C.P.","year":"2012","unstructured":"Kamm C.P.; El-Koussy M.; Humpert S.; Findling O.; Bredow F.; Burren Y.; Schwegler G.; Sch\u00f6tt D.; Donati F.; M\u00fcller M.; Goebels N.; M\u00fcller F.; Slotboom J.; Tettenborn B.; Kappos L.; Naegelin Y.; Mattle H.P.; Atorvastatin added to interferon \u03b2 for relapsing multiple sclerosis: A randomized controlled trial. J Neurol  2012,259(11),2401-2413","journal-title":"J Neurol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1590\/S0102-86502007000700012","volume":"22","author":"Rego A.C.M.","year":"2007","unstructured":"Rego A.C.M.; Ara\u00fajo Filho I.; Damasceno B.P.G.L.; Egito E.S.T.; Silveira I.A.; Brand\u00e3o-Neto J.; Medeiros A.C.; Simvastatin improves the healing of infected skin wounds of rats. Acta Cir Bras  2007,22(Suppl. 1),57-63","journal-title":"Acta Cir Bras"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1161\/01.CIR.0000034048.38910.91","volume":"106","author":"Pruefer D.","year":"2002","unstructured":"Pruefer D.; Makowski J.; Schnell M.; Buerke U.; Dahm M.; Oelert H.; Sibelius U.; Grandel U.; Grimminger F.; Seeger W.; Meyer J.; Darius H.; Buerke M.; Simvastatin inhibits inflammatory properties of Staphylococcus aureus alpha-toxin. Circulation  2002,106(16),2104-2110","journal-title":"Circulation"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jdermsci.2006.04.006","volume":"44","author":"Otuki M.F.","year":"2006","unstructured":"Otuki M.F.; Pietrovski E.F.; Cabrini D.A.; Topical simvastatin: Preclinical evidence for a treatment of skin inflammatory conditions. J Dermatol Sci  2006,44(1),45-47","journal-title":"J Dermatol Sci"},{"key":"ref=60","volume":"2013","author":"Jameel A","year":"2013","unstructured":"Jameel A; Ooi KG-J; Jeffs NR; Galatowicz G; Lightman SL; Calder VL; Statin modulation of human T-cell proliferation, IL-1 and IL-17 production, and IFN-T cell expression: synergy with conventional immunosuppressive agents. Int J Inflamm  2013,2013","journal-title":"Int J Inflamm"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"6720","DOI":"10.4049\/jimmunol.169.12.6720","volume":"169","author":"St\u00fcve O.","year":"2002","unstructured":"St\u00fcve O.; Youssef S.; Slavin A.J.; King C.L.; Patarroyo J.C.; Hirschberg D.L.; Brickey W.J.; Soos J.M.; Piskurich J.F.; Chapman H.A.; Zamvil S.S.; The role of the MHC class II transactivator in class II expression and antigen presentation by astrocytes and in susceptibility to central nervous system autoimmune disease. J Immunol  2002,169(12),6720-6732","journal-title":"J Immunol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1007\/s00417-021-05243-8","volume":"259","author":"Sobrin L.","year":"2021","unstructured":"Sobrin L.; Yu Y.; Han S.; Susarla G.; Kempen J.H.; Hubbard R.A.; VanderBeek B.L.; Decreased risk of non-infectious anterior uveitis with statin therapy in a large healthcare claims database. Graefes Arch Clin Exp Ophthalmol  2021,259(9),2783-2793","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/j.1365-2567.2010.03269.x","volume":"130","author":"Kim Y.C.","year":"2010","unstructured":"Kim Y.C.; Kim K.K.; Shevach E.M.; Simvastatin induces Foxp3+ T regulatory cells by modulation of transforming growth factor-\u03b2 signal transduction. Immunology  2010,130(4),484-493","journal-title":"Immunology"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.0906-6705.2004.00208.x","volume":"13","author":"Namazi M.R.","year":"2004","unstructured":"Namazi M.R.; Statins: novel additions to the dermatologic arsenal? Exp Dermatol  2004,13(6),337-339","journal-title":"Exp Dermatol"},{"key":"ref=65","first-page":"CD003697","author":"Dellavalle R.P.","year":"2005","unstructured":"Dellavalle R.P.; Drake A.; Graber M.; Heilig L.F.; Hester E.J.; Johnson K.R.; McNealy K.; Schilling L.; Statins and fibrates for preventing melanoma. Cochrane Database Syst Rev  2005(4),CD003697","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1093\/eurheartj\/ehn138","volume":"29","author":"Guasti L.","year":"2008","unstructured":"Guasti L.; Marino F.; Cosentino M.; Maio R.C.; Rasini E.; Ferrari M.; Castiglioni L.; Klersy C.; Gaudio G.; Grandi A.M.; Lecchini S.; Venco A.; Prolonged statin-associated reduction in neutrophil reactive oxygen species and angiotensin II type 1 receptor expression: 1-year follow-up. Eur Heart J  2008,29(9),1118-1126","journal-title":"Eur Heart J"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1016\/j.numecd.2008.01.001","volume":"18","author":"Goldstein M.R.","year":"2008","unstructured":"Goldstein M.R.; Mascitelli L.; Pezzetta F.; Statins, leptin and regulatory T cells. Nutr Metab Cardiovasc Dis  2008,18(6),e27","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"997","DOI":"10.5551\/jat.24398","volume":"21","author":"Lim S.","year":"2014","unstructured":"Lim S.; Barter P.; Antioxidant effects of statins in the management of cardiometabolic disorders. J Atheroscler Thromb  2014,21(10),997-1010","journal-title":"J Atheroscler Thromb"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s11936-005-0031-1","volume":"7","author":"Sorrentino S.","year":"2005","unstructured":"Sorrentino S.; Landmesser U.; Nonlipid-lowering effects of statins. Curr Treat Options Cardiovasc Med  2005,7(6),459-466","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/j.1440-1681.2007.04853.x","volume":"35","author":"Ajith T.A.","year":"2008","unstructured":"Ajith T.A.; Riji T.; Anu V.; In vitro anti-oxidant and DNA protective effects of the novel 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor rosuvastatin. Clin Exp Pharmacol Physiol  2008,35(5-6),625-629","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/S0006-291X(05)81334-8","volume":"180","author":"Vincent T.S.","year":"1991","unstructured":"Vincent T.S.; W\u00fclfert E.; Merler E.; Inhibition of growth factor signaling pathways by lovastatin. Biochem Biophys Res Commun  1991,180(3),1284-1289","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1002\/art.21723","volume":"54","author":"Louneva N.","year":"2006","unstructured":"Louneva N.; Huaman G.; Fertala J.; Jim\u00e9nez S.A.; Inhibition of systemic sclerosis dermal fibroblast type I collagen production and gene expression by simvastatin. Arthritis Rheum  2006,54(4),1298-1308","journal-title":"Arthritis Rheum"},{"key":"ref=73","first-page":"263","volume":"13","author":"Khoshneviszadeh M.","year":"2014","unstructured":"Khoshneviszadeh M.; Ashkani-Esfahani S.; Namazi M.R.; Noorafshan A.; Geramizadeh B.; Miri R.; Topical simvastatin enhances tissue regeneration in full-thickness skin wounds in rat models. Iran J Pharm Res  2014,13(1),263-269","journal-title":"Iran J Pharm Res"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1074\/jbc.M117.811240","volume":"293","author":"Sawaya A.P.","year":"2018","unstructured":"Sawaya A.P.; Pastar I.; Stojadinovic O.; Lazovic S.; Davis S.C.; Gil J.; Kirsner R.S.; Tomic-Canic M.; Topical mevastatin promotes wound healing by inhibiting the transcription factor c-Myc via the glucocorticoid receptor and the long non-coding RNA Gas5. J Biol Chem  2018,293(4),1439-1449","journal-title":"J Biol Chem"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.1167\/iovs.07-1610","volume":"49","author":"Meyer-ter-Vehn T.","year":"2008","unstructured":"Meyer-ter-Vehn T.; Katzenberger B.; Han H.; Grehn F.; Schlunck G.; Lovastatin inhibits TGF-\u03b2-induced myofibroblast transdifferentiation in human tenon fibroblasts. Invest Ophthalmol Vis Sci  2008,49(9),3955-3960","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1183\/09031936.00134707","volume":"35","author":"Kamio K.","year":"2010","unstructured":"Kamio K.; Liu X.D.; Sugiura H.; Togo S.; Kawasaki S.; Wang X.; Ahn Y.; Hogaboam C.; Rennard S.I.; Statins inhibit matrix metalloproteinase release from human lung fibroblasts. Eur Respir J  2010,35(3),637-646","journal-title":"Eur Respir J"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/0140-6736(91)93208-Q","volume":"337","author":"Oliver M.F.","year":"1991","unstructured":"Oliver M.F.; Might treatment of hypercholesterolaemia increase non-cardiac mortality? Lancet  1991,337(8756),1529-1531","journal-title":"Lancet"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/nrc1751","volume":"5","author":"Demierre M.F.","year":"2005","unstructured":"Demierre M.F.; Higgins P.D.R.; Gruber S.B.; Hawk E.; Lippman S.M.; Statins and cancer prevention. Nat Rev Cancer  2005,5(12),930-942","journal-title":"Nat Rev Cancer"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1146\/annurev.biochem.68.1.157","volume":"68","author":"Edwards P.A.","year":"1999","unstructured":"Edwards P.A.; Ericsson J.; Sterols and isoprenoids: Signaling molecules derived from the cholesterol biosynthetic pathway. Annu Rev Biochem  1999,68(1),157-185","journal-title":"Annu Rev Biochem"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1177\/153537020422900701","volume":"229","author":"Mo H.","year":"2004","unstructured":"Mo H.; Elson C.E.; Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention. Exp Biol Med (Maywood)  2004,229(7),567-585","journal-title":"Exp Biol Med (Maywood)"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/jphp.12707","volume":"69","author":"Safwat S.","year":"2017","unstructured":"Safwat S.; Ishak R.A.; Hathout R.M.; Mortada N.D.; Statins anticancer targeted delivery systems: re-purposing an old molecule. J Pharm Pharmacol  2017,69(6),613-624","journal-title":"J Pharm Pharmacol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"S101","DOI":"10.1016\/S0021-9150(97)00319-5","volume":"137","author":"Bellosta S.","year":"1998","unstructured":"Bellosta S.; Bernini F.; Ferri N.; Quarato P.; Canavesi M.; Arnaboldi L.; Fumagalli R.; Paoletti R.; Corsini A.; Direct vascular effects of HMG-CoA reductase inhibitors. Atherosclerosis  1998,137(Suppl.),S101-S109","journal-title":"Atherosclerosis"},{"key":"ref=83","first-page":"10","volume":"9","author":"Chan K.K.","year":"2003","unstructured":"Chan K.K.; Oza A.M.; Siu L.L.; The statins as anticancer agents. Clin Cancer Res  2003,9(1),10-19","journal-title":"Clin Cancer Res"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.4065\/77.10.1085","volume":"77","author":"Wright R.S.","year":"2002","unstructured":"Wright R.S.; Murphy J.G.; Bybee K.A.; Kopecky S.L.; LaBlanche J.M.; Statin lipid-lowering therapy for acute myocardial infarction and unstable angina: Efficacy and mechanism of benefit. Mayo Clin Proc  2002,77(10),1085-1092","journal-title":"Mayo Clin Proc"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0898-6568(02)00124-9","volume":"15","author":"Denoyelle C.","year":"2003","unstructured":"Denoyelle C.; Albanese P.; Uzan G.; Hong L.; Vannier J.P.; Soria J.; Soria C.; Molecular mechanism of the anti-cancer activity of cerivastatin, an inhibitor of HMG-CoA reductase, on aggressive human breast cancer cells. Cell Signal  2003,15(3),327-338","journal-title":"Cell Signal"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"7797","DOI":"10.1073\/pnas.96.14.7797","volume":"96","author":"Rao S.","year":"1999","unstructured":"Rao S.; Porter D.C.; Chen X.; Herliczek T.; Lowe M.; Keyomarsi K.; Lovastatin-mediated G  arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase. Proc Natl Acad Sci USA  1999,96(14),7797-7802","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/89058","volume":"7","author":"Weitz-Schmidt G.","year":"2001","unstructured":"Weitz-Schmidt G.; Welzenbach K.; Brinkmann V.; Kamata T.; Kallen J.; Bruns C.; Cottens S.; Takada Y.; Hommel U.; Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat Med  2001,7(6),687-692","journal-title":"Nat Med"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0002-9149(00)00910-3","volume":"86","author":"Pedersen T.R.","year":"2000","unstructured":"Pedersen T.R.; Wilhelmsen L.; F\u00e6rgeman O.; Strandberg T.E.; Thorgeirsson G.; Troedsson L.; Kristianson J.; Berg K.; Cook T.J.; Haghfelt T.; Kjekshus J.; Miettinen T.; Olsson A.G.; Py\u00f6r\u00e4l\u00e4 K.; Wedel H.; Follow-up study of patients randomized in the scandinavian simvastatin survival study (4S) of cholesterol lowering. Am J Cardiol  2000,86(3),257-262","journal-title":"Am J Cardiol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.cellsig.2009.12.010","volume":"22","author":"Ghosh-Choudhury N.","year":"2010","unstructured":"Ghosh-Choudhury N.; Mandal C.C.; Ghosh-Choudhury N.; Ghosh Choudhury G.; Simvastatin induces derepression of PTEN expression via NF\u03baB to inhibit breast cancer cell growth. Cell Signal  2010,22(5),749-758","journal-title":"Cell Signal"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/ncponc0097","volume":"2","author":"Katz M.S.","year":"2005","unstructured":"Katz M.S.; Therapy Insight: potential of statins for cancer chemoprevention and therapy. Nat Clin Pract Oncol  2005,2(2),82-89","journal-title":"Nat Clin Pract Oncol"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00228-018-2570-x","volume":"75","author":"Ghasemi A.","year":"2019","unstructured":"Ghasemi A.; Ghashghai Z.; Akbari J.; Yazdani-Charati J.; Salehifar E.; Hosseinimehr S.J.; Topical atorvastatin 1% for prevention of skin toxicity in patients receiving radiation therapy for breast cancer: A randomized, double-blind, placebo-controlled trial. Eur J Clin Pharmacol  2019,75(2),171-178","journal-title":"Eur J Clin Pharmacol"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"7393","DOI":"10.1021\/acsanm.9b01924","volume":"2","author":"Capanema N.S.V.","year":"2019","unstructured":"Capanema N.S.V.; Carvalho I.C.; Mansur A.A.P.; Carvalho S.M.; Lage A.P.; Mansur H.S.; Hybrid hydrogel composed of carboxymethylcellulose\u2013silver nanoparticles\u2013doxorubicin for anticancer and antibacterial therapies against melanoma skin cancer cells. ACS Appl Nano Mater  2019,2(11),7393-7408","journal-title":"ACS Appl Nano Mater"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"105019","DOI":"10.1016\/j.chemphyslip.2020.105019","volume":"234","author":"Akbarzadeh I.","year":"2021","unstructured":"Akbarzadeh I.; Keramati M.; Azadi A.; Afzali E.; Shahbazi R.; chiani M.; Norouzian D.; Bakhshandeh H.; Optimization, physicochemical characterization, and antimicrobial activity of a novel simvastatin nano-niosomal gel against E. coli and S. aureus. Chem Phys Lipids  2021,234,105019","journal-title":"Chem Phys Lipids"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"102226","DOI":"10.1016\/j.jddst.2020.102226","volume":"61","author":"Malta R.","year":"2021","unstructured":"Malta R.; Loureiro J.B.; Costa P.; Sousa E.; Pinto M.; Saraiva L.; Amaral M.H.; Development of lipid nanoparticles containing the xanthone LEM2 for topical treatment of melanoma. J Drug Deliv Sci Technol  2021,61,102226","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"106651","DOI":"10.1016\/j.clay.2022.106651","volume":"228","author":"Suterio N.","year":"2022","unstructured":"Suterio N.; Bazzo G.C.; Rauber G.S.; Silva A.H.; Caon T.; Parize A.L.; Creczynski-Pasa T.B.; Stulzer H.K.; Laponite gel formulation containing simvastatin for melanoma treatment. Appl Clay Sci  2022,228,106651","journal-title":"Appl Clay Sci"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/S0300-8932(02)76713-4","volume":"55","author":"Llevadot J.","year":"2002","unstructured":"Llevadot J.; Asahara T.; Efecto de las estatinas en la inducci\u00f3n de angiog\u00e9nesis y vasculog\u00e9nesis. Rev Esp Cardiol  2002,55(8),838-844","journal-title":"Rev Esp Cardiol"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/79510","volume":"6","author":"Kureishi Y.","year":"2000","unstructured":"Kureishi Y.; Luo Z.; Shiojima I.; Bialik A.; Fulton D.; Lefer D.J.; Sessa W.C.; Walsh K.; The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med  2000,6(9),1004-1010","journal-title":"Nat Med"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/21224","volume":"399","author":"Dimmeler S.","year":"1999","unstructured":"Dimmeler S.; Fleming I.; Fisslthaler B.; Hermann C.; Busse R.; Zeiher A.M.; Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature  1999,399(6736),601-605","journal-title":"Nature"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/21218","volume":"399","author":"Fulton D.","year":"1999","unstructured":"Fulton D.; Gratton J.P.; McCabe T.J.; Fontana J.; Fujio Y.; Walsh K.; Franke T.F.; Papapetropoulos A.; Sessa W.C.; Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature  1999,399(6736),597-601","journal-title":"Nature"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0014-5793(01)02337-7","volume":"495","author":"Vincent L.","year":"2001","unstructured":"Vincent L.; Chen W.; Hong L.; Mirshahi F.; Mishal Z.; Mirshahi-Khorassani T.; Vannier J.P.; Soria J.; Soria C.; Inhibition of endothelial cell migration by cerivastatin, an HMG-CoA reductase inhibitor: Contribution to its anti-angiogenic effect. FEBS Lett  2001,495(3),159-166","journal-title":"FEBS Lett"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1161\/01.RES.0000014081.30867.F8","volume":"90","author":"Urbich C.","year":"2002","unstructured":"Urbich C.; Dernbach E.; Zeiher A.M.; Dimmeler S.; Double-edged role of statins in angiogenesis signaling. Circ Res  2002,90(6),737-744","journal-title":"Circ Res"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1016\/j.ajpath.2012.08.023","volume":"181","author":"Asai J.","year":"2012","unstructured":"Asai J.; Takenaka H.; Hirakawa S.; Sakabe J.; Hagura A.; Kishimoto S.; Maruyama K.; Kajiya K.; Kinoshita S.; Tokura Y.; Katoh N.; Topical simvastatin accelerates wound healing in diabetes by enhancing angiogenesis and lymphangiogenesis. Am J Pathol  2012,181(6),2217-2224","journal-title":"Am J Pathol"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/j.1742-481X.2011.00888.x","volume":"9","author":"Farsaei S.","year":"2012","unstructured":"Farsaei S.; Khalili H.; Farboud E.S.; Potential role of statins on wound healing: review of the literature. Int Wound J  2012,9(3),238-247","journal-title":"Int Wound J"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.lfs.2003.07.032","volume":"74","author":"Simko F.","year":"2004","unstructured":"Simko F.; Matuskova J.; Luptak I.; Krajcirovicova K.; Kucharska J.; Gvozdjakova A.; Babal P.; Pechanova O.; Effect of simvastatin on remodeling of the left ventricle and aorta in L-NAME-induced hypertension. Life Sci  2004,74(10),1211-1224","journal-title":"Life Sci"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"10265","DOI":"10.1074\/jbc.M110.188268","volume":"286","author":"Vukelic S.","year":"2011","unstructured":"Vukelic S.; Stojadinovic O.; Pastar I.; Rabach M.; Krzyzanowska A.; Lebrun E.; Davis S.C.; Resnik S.; Brem H.; Tomic-Canic M.; Cortisol synthesis in epidermis is induced by IL-1 and tissue injury. J Biol Chem  2011,286(12),10265-10275","journal-title":"J Biol Chem"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1002\/jcp.25357","volume":"231","author":"Pastar I.","year":"2016","unstructured":"Pastar I.; Stojadinovic O.; Sawaya A.P.; Stone R.C.; Lindley L.E.; Ojeh N.; Vukelic S.; Samuels H.H.; Tomic-Canic M.; Skin metabolite, farnesyl pyrophosphate, regulates epidermal response to inflammation, oxidative stress, and migration. J Cell Physiol  2016,231(11),2452-2463","journal-title":"J Cell Physiol"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"18S","DOI":"10.1097\/PRS.0000000000002682","volume":"138","author":"Lindley L.E.","year":"2016","unstructured":"Lindley L.E.; Stojadinovic O.; Pastar I.; Tomic-Canic M.; Biology and biomarkers for wound healing. Plast Reconstr Surg  2016,138(3)(Suppl.),18S-28S","journal-title":"Plast Reconstr Surg"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/wrr.12142","volume":"22","author":"Stojadinovic O.","year":"2014","unstructured":"Stojadinovic O.; Pastar I.; Nusbaum A.G.; Vukelic S.; Krzyzanowska A.; Tomic-Canic M.; Deregulation of epidermal stem cell niche contributes to pathogenesis of nonhealing venous ulcers. Wound Repair Regen  2014,22(2),220-227","journal-title":"Wound Repair Regen"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/MAJ.0b013e3181aaf209","volume":"338","author":"Toker S.","year":"2009","unstructured":"Toker S.; Gulcan E.; \u00c7ayc\u0131 M.K.; Olgun E.G.; Erbilen E.; \u00d6zay Y.; Topical atorvastatin in the treatment of diabetic wounds. Am J Med Sci  2009,338(3),201-204","journal-title":"Am J Med Sci"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1166\/jbn.2009.1016","volume":"5","author":"Erdogan S.","year":"2009","unstructured":"Erdogan S.; Liposomal nanocarriers for tumor imaging. J Biomed Nanotechnol  2009,5(2),141-150","journal-title":"J Biomed Nanotechnol"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.addr.2011.01.012","volume":"63","author":"Prow T.W.","year":"2011","unstructured":"Prow T.W.; Grice J.E.; Lin L.L.; Faye R.; Butler M.; Becker W.; Wurm E.M.T.; Yoong C.; Robertson T.A.; Soyer H.P.; Roberts M.S.; Nanoparticles and microparticles for skin drug delivery. Adv Drug Deliv Rev  2011,63(6),470-491","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0168-3659(96)01609-4","volume":"46","author":"Schmalfu\u00df U.","year":"1997","unstructured":"Schmalfu\u00df U.; Neubert R.; Wohlrab W.; Modification of drug penetration into human skin using microemulsions. J Control Release  1997,46(3),279-285","journal-title":"J Control Release"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"e1294","DOI":"10.1097\/GOX.0000000000001294","volume":"5","author":"Jia S","year":"2017","unstructured":"Jia S; Xie P; Hong SJ; Galiano RD; Mustoe TA; Local application of statins significantly reduced hypertrophic scarring in a rabbit ear model. Plast Reconstr Surg Glob Open  2017,5(6),e1294","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/wrr.12811","volume":"28","author":"Xie P.","year":"2020","unstructured":"Xie P.; Dolivo D.M.; Jia S.; Cheng X.; Salcido J.; Galiano R.D.; Hong S.J.; Mustoe T.A.; Liposome-encapsulated statins reduce hypertrophic scarring through topical application. Wound Repair Regen  2020,28(4),460-469","journal-title":"Wound Repair Regen"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s13346-020-00733-4","volume":"10","author":"Yadav M.","year":"2020","unstructured":"Yadav M.; Schiavone N.; Guzman-Aranguez A.; Giansanti F.; Papucci L.; Perez de Lara M.J.; Singh M.; Kaur I.P.; Atorvastatin-loaded solid lipid nanoparticles as eye drops: proposed treatment option for age-related macular degeneration (AMD). Drug Deliv Transl Res  2020,10(4),919-944","journal-title":"Drug Deliv Transl Res"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1166\/jbn.2017.2474","volume":"13","author":"Hao Y.","year":"2017","unstructured":"Hao Y.; Li W.; Zhou X.; Yang F.; Qian Z.; Microneedles-based transdermal drug delivery systems: A review. J Biomed Nanotechnol  2017,13(12),1581-1597","journal-title":"J Biomed Nanotechnol"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"564","DOI":"10.3109\/10717544.2014.935532","volume":"23","author":"Marwah H.","year":"2016","unstructured":"Marwah H.; Garg T.; Goyal A.K.; Rath G.; Permeation enhancer strategies in transdermal drug delivery. Drug Deliv  2016,23(2),564-578","journal-title":"Drug Deliv"},{"key":"ref=118","doi-asserted-by":"publisher","author":"Ranade V.V.","unstructured":"Ranade V.V.; Cannon J.B.;   (2011). Drug Delivery Systems (3 ed.). CRC Press.","DOI":"10.1201\/b10846"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12944-019-1139-8","volume":"18","author":"Korani S.","year":"2019","unstructured":"Korani S.; Bahrami S.; Korani M.; Banach M.; Johnston T.P.; Sahebkar A.; Parenteral systems for statin delivery: A review. Lipids Health Dis  2019,18(1),193","journal-title":"Lipids Health Dis"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/j.cclet.2018.10.037","volume":"29","author":"Zhou X.","year":"2018","unstructured":"Zhou X.; Hao Y.; Yuan L.; Pradhan S.; Shrestha K.; Pradhan O.; Liu H.; Li W.; Nano-formulations for transdermal drug delivery: A review. Chin Chem Lett  2018,29(12),1713-1724","journal-title":"Chin Chem Lett"},{"key":"ref=121","author":"Lane E.","year":"2005","unstructured":"Lane E.;  Transdermal delivery system for statin combination therapy  2005","journal-title":"Transdermal delivery system for statin combination therapy"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1111\/j.2042-7158.2011.01273.x","volume":"63","author":"Tiwari R.","year":"2011","unstructured":"Tiwari R.; Pathak K.; Statins therapy: A review on conventional and novel formulation approaches. J Pharm Pharmacol  2011,63(8),983-998","journal-title":"J Pharm Pharmacol"},{"key":"ref=123","first-page":"1536","volume":"23","author":"Zidan A.S.","year":"2016","unstructured":"Zidan A.S.; Hosny K.M.; Ahmed O.A.; Fahmy U.A.; Assessment of simvastatin niosomes for pediatric transdermal drug delivery. Drug Deliv  2016,23(5),1536-1549","journal-title":"Drug Deliv"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.xphs.2015.12.002","volume":"105","author":"Xiang N.","year":"2016","unstructured":"Xiang N.; Zhou X.; He X.; Zhang Y.; Zhang J.; Zhang Z.R.; Sun X.; Gong T.; Fu Y.; An injectable gel platform for the prolonged therapeutic effect of pitavastatin in the management of hyperlipidemia. J Pharm Sci  2016,105(3),1148-1155","journal-title":"J Pharm Sci"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"554","DOI":"10.4103\/2230-8210.163106","volume":"19","author":"Vasnawala H.","year":"2015","unstructured":"Vasnawala H.; Kavalipati N.; Shah J.; Ramakrishan A.; Pleiotropic effects of statins. Indian J Endocrinol Metab  2015,19(5),554-562","journal-title":"Indian J Endocrinol Metab"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1146\/annurev.pharmtox.45.120403.095748","volume":"45","author":"Liao J.K.","year":"2005","unstructured":"Liao J.K.; Laufs U.; Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol  2005,45(1),89-118","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"LPI.S37450","DOI":"10.4137\/LPI.S37450","volume":"9","author":"Davies J.T.","year":"2016","unstructured":"Davies J.T.; Delfino S.F.; Feinberg C.E.; Johnson M.F.; Nappi V.L.; Olinger J.T.; Schwab A.P.; Swanson H.I.; Current and Emerging Uses of Statins in Clinical Therapeutics: A Review. Lipid Insights  2016,9,LPI.S37450","journal-title":"Lipid Insights"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"265sr6","DOI":"10.1126\/scitranslmed.3009337","volume":"6","author":"Eming SA","year":"2014","unstructured":"Eming SA; Martin P; Tomic-Canic M; Wound repair and regeneration: mechanisms, signaling, and translation. Sci Transl Med  2014,6(265),265sr6","journal-title":"Sci Transl Med"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/j.1600-0765.2007.01024.x","volume":"43","author":"Seto H.","year":"2008","unstructured":"Seto H.; Ohba H.; Tokunaga K.; Hama H.; Horibe M.; Nagata T.; Topical administration of simvastatin recovers alveolar bone loss in rats. J Periodontal Res  2008,43(3),261-267","journal-title":"J Periodontal Res"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/j.1600-0501.2007.01508.x","volume":"19","author":"Moriyama Y.","year":"2008","unstructured":"Moriyama Y.; Ayukawa Y.; Ogino Y.; Atsuta I.; Koyano K.; Topical application of statin affects bone healing around implants. Clin Oral Implants Res  2008,19(6),600-605","journal-title":"Clin Oral Implants Res"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/ID.0000000000000051","volume":"23","author":"Mansour G.","year":"2014","unstructured":"Mansour G.; Al Ashwah A.; Koura A.; Evaluation of simvastatin grafting around immediate dental implants in dogs. Implant Dent  2014,23(2),195-199","journal-title":"Implant Dent"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/j.actbio.2009.10.045","volume":"6","author":"Moriyama Y.","year":"2010","unstructured":"Moriyama Y.; Ayukawa Y.; Ogino Y.; Atsuta I.; Todo M.; Takao Y.; Koyano K.; Local application of fluvastatin improves peri-implant bone quantity and mechanical properties: A rodent study. Acta Biomater  2010,6(4),1610-1618","journal-title":"Acta Biomater"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"33458","DOI":"10.1038\/srep33458","volume":"6","author":"Parihar S.P.","year":"2016","unstructured":"Parihar S.P.; Hartley M.A.; Hurdayal R.; Guler R.; Brombacher F.; Topical simvastatin as host-directed therapy against severity of cutaneous leishmaniasis in mice. Sci Rep  2016,6(1),33458","journal-title":"Sci Rep"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"16407","DOI":"10.1038\/srep16407","volume":"5","author":"Thangamani S.","year":"2015","unstructured":"Thangamani S.; Mohammad H.; Abushahba M.F.N.; Hamed M.I.; Sobreira T.J.P.; Hedrick V.E.; Paul L.N.; Seleem M.N.; Exploring simvastatin, an antihyperlipidemic drug, as a potential topical antibacterial agent. Sci Rep  2015,5(1),16407","journal-title":"Sci Rep"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"852","DOI":"10.2174\/1389201021666200217103302","volume":"21","author":"Casta\u00f1eda P.S.","year":"2020","unstructured":"Casta\u00f1eda P.S.; Dom\u00ednguez Delgado C.L.; Cruz I.M.R.; Contreras L.M.M.; Trinidad E.M.M.; Cervantes M.L.; Escobar-Ch\u00e1vez J.J.; Development of poly (methyl vinyl ether-alt-maleic acid) microneedles for transdermal delivery of atorvastatin calcium. Curr Pharm Biotechnol  2020,21(9),852-861","journal-title":"Curr Pharm Biotechnol"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"235","DOI":"10.22159\/ijap.2018v10i5.26657","volume":"10","author":"Anod H.V.","year":"2018","unstructured":"Anod H.V.; Gupta N.V.; Gowda D.V.; M M.; Preparation and evaluation of simvastatin transdermal film. Int J Appl Pharm  2018,10(5),235","journal-title":"Int J Appl Pharm"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"119073","DOI":"10.1016\/j.ijpharm.2020.119073","volume":"578","author":"Shaker D.S.","year":"2020","unstructured":"Shaker D.S.; Ishak R.A.H.; Elhuoni M.A.; Ghoneim A.M.; Boosting transdermal delivery of atorvastatin calcium via o\/w nanoemulsifying system: Two-step optimization, ex vivo and in vivo evaluation. Int J Pharm  2020,578,119073","journal-title":"Int J Pharm"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1080\/10717544.2019.1686087","volume":"26","author":"El Menshawe S.F.","year":"2019","unstructured":"El Menshawe S.F.; Nafady M.M.; Aboud H.M.; Kharshoum R.M.; Elkelawy A.M.M.H.; Hamad D.S.; Transdermal delivery of fluvastatin sodium via tailored spanlastic nanovesicles: mitigated Freund\u2019s adjuvant-induced rheumatoid arthritis in rats through suppressing p38 MAPK signaling pathway. Drug Deliv  2019,26(1),1140-1154","journal-title":"Drug Deliv"},{"key":"ref=139","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jconrel.2017.03.039","volume":"254","author":"Mahmoud MO","year":"2017","unstructured":"Mahmoud MO; Aboud HM; Hassan AH; Ali AA; Johnston TP; Transdermal delivery of atorvastatin calcium from novel nanovesicular systems using polyethylene glycol fatty acid esters: Ameliorated effect without liver toxicity in poloxamer 407-induced hyperlipidemic rats. Journal of controlled release  2017,254,10-22","journal-title":"Journal of controlled release"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1007\/s00198-006-0079-0","volume":"17","author":"Gutierrez GE","year":"2006","unstructured":"Gutierrez GE; Lalka D; Garrett IR; Rossini G; Mundy GR; Transdermal application of lovastatin to rats causes profound increases in bone formation and plasma concentrations. Osteoporos Int  2006,17(7),1033-1042","journal-title":"Osteoporos Int"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1080\/00016357.2017.1403648","volume":"76","author":"Madi M.","year":"2018","unstructured":"Madi M.; Kassem A.; Topical simvastatin gel as a novel therapeutic modality for palatal donor site wound healing following free gingival graft procedure. Acta Odontol Scand  2018,76(3),212-219","journal-title":"Acta Odontol Scand"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1007\/s00268-016-3749-x","volume":"41","author":"Ala S.","year":"2017","unstructured":"Ala S.; Alvandipour M.; Saeedi M.; Hamidian M.; Shiva A.; Rahmani N.; Faramarzi F.; Effects of topical atorvastatin (2%) on posthemorrhoidectomy pain and wound healing: A randomized double-blind placebo-controlled clinical trial. World J Surg  2017,41(2),596-602","journal-title":"World J Surg"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/phar.1339","volume":"34","author":"Farsaei S.","year":"2014","unstructured":"Farsaei S.; Khalili H.; Farboud E.S.; Karimzadeh I.; Beigmohammadi M.T.; Efficacy of topical atorvastatin for the treatment of pressure ulcers: A randomized clinical trial. Pharmacotherapy  2014,34(1),19-27","journal-title":"Pharmacotherapy"},{"key":"ref=144","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00520-007-0267-2","volume":"15","author":"Joshi R","year":"2007","unstructured":"Joshi R; Olver I; Keefe D; Marafioti T; Smith K.; A phase I study to assess the safety and activity of topical lovastatin (FP252S) for the prevention of chemotherapy-induced alopecia. Supportive Care Cancer  2007,15(9),1109-1112","journal-title":"Supportive Care Cancer"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2174\/1574884713666180821143545","volume":"13","author":"Ahmadvand A.","year":"2019","unstructured":"Ahmadvand A.; Yazdanfar A.; Yasrebifar F.; Mohammadi Y.; Mahjub R.; Mehrpooya M.; Evaluating the effects of oral and topical simvastatin in the treatment of acne vulgaris: A double-blind, randomized, placebo-controlled clinical trial. Curr Clin Pharmacol  2019,13(4),279-283","journal-title":"Curr Clin Pharmacol"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"109","DOI":"10.4155\/tde.10.16","volume":"1","author":"Paudel K.S.","year":"2010","unstructured":"Paudel K.S.; Milewski M.; Swadley C.L.; Brogden N.K.; Ghosh P.; Stinchcomb A.L.; Challenges and opportunities in dermal\/transdermal delivery. Ther Deliv  2010,1(1),109-131","journal-title":"Ther Deliv"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0928-0987(01)00167-1","volume":"14","author":"Barry B.W.","year":"2001","unstructured":"Barry B.W.; Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci  2001,14(2),101-114","journal-title":"Eur J Pharm Sci"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ijpharm.2013.08.019","volume":"456","author":"Raza K.","year":"2013","unstructured":"Raza K.; Singh B.; Lohan S.; Sharma G.; Negi P.; Yachha Y.; Katare O.P.; Nano-lipoidal carriers of tretinoin with enhanced percutaneous absorption, photostability, biocompatibility and anti-psoriatic activity. Int J Pharm  2013,456(1),65-72","journal-title":"Int J Pharm"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3109\/02652048.2012.717115","volume":"30","author":"Raza K.","year":"2013","unstructured":"Raza K.; Katare O.P.; Setia A.; Bhatia A.; Singh B.; Improved therapeutic performance of dithranol against psoriasis employing systematically optimized nanoemulsomes. J Microencapsul  2013,30(3),225-236","journal-title":"J Microencapsul"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"481","DOI":"10.2174\/1389200218666170222150555","volume":"18","author":"Kurmi B.D.","year":"2017","unstructured":"Kurmi B.D.; Tekchandani P.; Paliwal R.; Paliwal S.R.; Transdermal drug delivery: Opportunities and challenges for controlled delivery of therapeutic agents using nanocarriers. Curr Drug Metab  2017,18(5),481-495","journal-title":"Curr Drug Metab"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867330666230508141434","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/216658\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867330666230508141434","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T12:45:59Z","timestamp":1716209159000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/216658\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":150,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867330666230508141434","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-10-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-19","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}